查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1496688

連續腎臟替代療法市場：按產品、方式、年齡層、適應症和最終用戶 - 2024-2030 年全球預測

Continuous Renal Replacement Therapy Market by Product, Modality, Age Group, Indication, End User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

持續性腎臟替代治療市場規模預計2023年為142.8億美元，2024年達到154.9億美元，預計2030年將達到253.7億美元，複合年成長率為8.55%。

連續性腎臟替代療法（CRRT）是一種用於連續透析以維持溶質和液體穩態的專門治療方法。 CRRT 透過模仿腎臟從血液中清除廢物、多餘液體和電解質的自然功能，同時保持最佳酸鹼平衡，提供持續的腎臟支持。由於多種因素，CRRT 經歷了顯著成長，包括全球 AKI 盛行率的增加以及體外透析和碎石術的技術進步。此外，CRRT在間歇性血液淨化方面的顯著優勢正在推動市場擴張。然而，對腎臟替代治療的高成本和治療期間潛在併發症的擔憂阻礙了 CRRT 的發展。此外，持續的技術創新和研究工作正在為 CRRT 的未來做出貢獻，包括開發具有改進的生物相容性的新型膜材料、先進的治療方法以及擴大 CCRT 系統在兒科患者中的應用。

主要市場統計
基準年[2023] 142.8億美元
預測年份 [2024] 154.9億美元
預測年份 [2030] 253.7億美元
複合年成長率（%） 8.55%

區域洞察

在美洲，美國和加拿大等國家佔據了 CRRT 市場的很大佔有率，推動成長的主要因素是腎臟疾病盛行率的增加、技術進步和主要參與者的研發活動。此外，在歐洲，主要製造商的存在、對先進治療的需求不斷增加以及政府支持政策（例如腎臟治療產品的歐洲 CE 標誌）都有助於 CRRT 市場的擴張。同時，在中東和非洲地區，由於人們對腎臟疾病的認知不斷提高，以及採用臨床研究支持的新治療方法的醫療基礎設施不斷發展，對 CRRT 解決方案的需求不斷增加。在亞太地區，中國、日本和印度是 CRRT 市場成長的主要貢獻者。這是由於大量腎臟病患者、不斷發展的醫療旅遊業、不斷擴大的醫療基礎設施以及允許在該地區快速採用先進技術的研究等因素造成的，因為重點是舉措。因此，製造商透過調整監管合規措施並與政府和組織建立策略聯盟來保持敏捷性，以在 CRRT 市場上留下印記。

FPNV定位矩陣

FPNV 定位矩陣對於評估供應商在連續性腎臟替代治療市場的定位至關重要。此矩陣提供了對供應商的全面評估，並檢查了與業務策略和產品滿意度相關的關鍵指標。這種詳細的評估使用戶能夠根據自己的要求做出明智的決定。根據評估結果，供應商被分為代表其成功程度的四個像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對連續性腎臟替代治療市場中供應商的現狀進行深入而詳細的評估。透過仔細比較和分析供應商的貢獻，您可以更深入地了解每個供應商的績效以及他們在爭奪市場佔有率時面臨的挑戰。這些貢獻包括整體收益、客戶群和其他重要指標。此外，該分析還提供了對該行業競爭性質的寶貴見解，包括在研究基準年期間觀察到的累積、分散主導地位和合併特徵等因素。有了這些詳細資訊，供應商可以做出更明智的決策並製定有效的策略，以在市場競爭中保持領先地位。

策略分析與建議

策略分析對於尋求在全球市場站穩腳跟的組織至關重要。對目前在連續性腎臟替代治療市場中的地位進行全面評估，使公司能夠做出符合其長期願望的明智決策。此關鍵評估涉及對組織的資源、能力和整體績效進行徹底分析，以確定核心優勢和需要改進的領域。

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 急性腎損傷（AKI）和慢性腎臟病（CKD）的發生率上升
      • 為兒科和新生兒患者提供改良的 CCRT 系統
    • 抑制因素
      • 連續性腎臟替代治療程序的高成本
    • 機會
      • 持續研發以提高 CRRT 的安全性和有效性
      • CRRT 設備和技術獲得政府有利核准
    • 任務
      • 與連續性腎臟替代治療相關的技術問題
  • 市場區隔分析
    • 產品：急性腎損傷 (AKI) 盛行率的不斷上升增加了對 CRRT 設備進行無縫治療程序的需求。
    • 方法：利用連續性靜脈血液濾過透析進行腎臟治療中的自由水管理
    • 年齡層：兒科族群 CRRT 要求的差異
    • 適應症：在體外腎臟治療中擴大採用非腎臟適應症
    • 最終用戶：增加醫院中 CRRT 設備的使用以滿足病患需求
  • 市場趨勢分析
    • 北美現有公司的 CRRT 已獲得政府的有利核准，並且還有擴展到南美市場的潛力。
    • 亞洲腎臟病患者數量的增加增加了持續腎臟替代治療的需求
    • 支持性腎臟健康政策和現有供應商的財務承諾促進了 CRRT 在歐洲、中東和非洲地區的發展。
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法規結構分析

第6章連續腎臟替代治療市場：依產品

  • CRRT系統
  • 透析液和置換液
  • 一次性的

第7章連續腎臟替代治療市場：按方式

  • 連續性靜脈血液濾過透析
  • 連續性靜脈血液透析機
  • 連續性靜脈血液濾過
  • 低速連續超過濾

第8章連續腎臟替代治療市場：依年齡層

  • 成人
  • 小兒科

第9章連續腎臟替代治療市場（按適應症）

  • 非腎
  • 腎

第10章連續腎臟替代治療市場：依最終用戶分類

  • 透析診所
  • 居家護理
  • 醫院

第11章美洲連續腎臟替代治療市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章亞太地區持續腎臟替代治療市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章歐洲、中東和非洲連續性腎臟替代治療市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • B. Braun 的 AQUAbase nX逆滲透系統獲得 FDA 批准
    • Quanta 獲得 FDA 510(k)核准，擴大連續性腎臟替代治療的適應症
    • Rockwell Medical 宣布與 B. Brown Medical 建立為期三年的共同促銷合作夥伴關係
    • Nuwellis 和 DaVita 合作開展超過濾治療試驗計畫
    • Baxter 和 Miromatrix 合作研究肝功能衰竭
    • PBMC 為透析患者推出新的腎臟治療方案
    • Sea Star Medical 與 Nuweris 合作治療腎臟疾病
    • Spectral Medical 宣布與 Infomed 成立策略合資企業，以加速 DIMI 和 SAMI透析設備的商業化。
    • 百特宣布美國FDA核准用於治療醫院急性腎衰竭患者的 ST 裝置

第15章競爭產品組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-433AB1DC293A

[187 Pages Report] The Continuous Renal Replacement Therapy Market size was estimated at USD 14.28 billion in 2023 and expected to reach USD 15.49 billion in 2024, at a CAGR 8.55% to reach USD 25.37 billion by 2030.

Continuous renal replacement therapy (CRRT) is a specialized medical treatment utilized for continuous dialysis to allow solute and fluid homeostasis. CRRT provides continuous renal support by mimicking the natural function of the kidneys in removing waste products, excess fluids, and electrolytes from the blood while maintaining optimal acid-base balance. The CRRT is witnessing significant growth due to several factors, including the increasing prevalence of AKI incidences globally and rising technological advancements in extracorporeal dialysis and lithotripsy. In addition, significant advantages of CRRT in intermittent blood purification boost the market expansion. However, the high cost associated with the renal replacement procedure and concerns over potential complications during therapies subsequently hampers the growth of CRRT. Moreover, ongoing innovation and research activities, including developing novel membrane materials and advanced therapy options with improved biocompatibility and widening uses of CCRT systems for pediatric patients, contribute to the future CRRT.

KEY MARKET STATISTICS
Base Year [2023] USD 14.28 billion
Estimated Year [2024] USD 15.49 billion
Forecast Year [2030] USD 25.37 billion
CAGR (%) 8.55%

Regional Insights

In the Americas, countries such as the United States and Canada hold a significant share of the CRRT market, with the major factors driving the growth, including the increasing prevalence of renal diseases and technological advancements and research & development activities by major companies. Additionally, in Europe, the presence of leading manufacturers, increased need for advanced therapies, and supportive government policies, such as European CE marking for renal therapy products, contribute to the expansion of the CRRT market. On the other hand, the Middle East and Africa region has witnessed a growth in need for CRRT solutions due to rising awareness about renal diseases and continuously developing healthcare infrastructure adopting new treatment options supported by clinical studies. In Asia-Pacific, China, Japan, and India are major contributors to the CRRT market growth due to factors including a large patient pool with kidney disorders, a growing medical tourism industry, and expanding healthcare infrastructure, coupled with an increasing focus on research initiatives enabling rapid adoption of advanced technologies in this region. As a result, manufacturers remain agile by adapting regulatory compliance measures and participating in strategic collaborations with governments and entities to form footprints in the CRRT market.

Market Insights

  • Market Dynamics

The market dynamics represent an ever-changing landscape of the Continuous Renal Replacement Therapy Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

    • Market Drivers
      • Rising incidences of acute kidney injury (AKI) and chronic kidney diseases (CKD)
      • Availability of improved CCRT systems for pediatric and neonatal patients
    • Market Restraints
      • High cost of continuous renal replacement therapy procedure
    • Market Opportunities
      • Ongoing research and development for enhanced safety and efficacy of CRRT
      • Favorable government approvals for CRRT machines and techniques
    • Market Challenges
      • Technical complications associated with continuous renal replacement therapy
  • Market Segmentation Analysis
    • Product: Growing prevalence toward acute kidney injury (AKI) boosting a need for CRRT devices for seamless treatment procedures
    • Modality: Utilization of continuous venovenous hemodiafiltration for liberal fluid management in renal therapies
    • Age Group: Differing CRRT requirements among pediatric population
    • Indication: Growing adoption of non-renal indications in extracorporeal renal therapies
    • End User: Increasing uses of CRRT devices in hospitals to cater a patients need
  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Continuous Renal Replacement Therapy Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Continuous Renal Replacement Therapy Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

B. Braun Receives FDA Clearance for AQUAbase nX Reverse Osmosis System

B. Braun Medical Inc. has obtained 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its AQUAbase nX Reverse Osmosis System. This innovative device offers dialysis patients access to high-quality water without the use of chemicals, boasting an impressive raw water conversion rate of up to 75%. [Published On: 2023-09-18]

Quanta Receives FDA 510(k) Clearance for Expanded Indication of Continuous Renal Replacement Therapies

Quanta Dialysis Technologies, a medical technology company, has announced that its Quanta Dialysis System has received FDA 510(k) approval for an expanded indication. This compact and user-friendly hemodialysis device now offers Continuous Renal Replacement Therapy (CRRT), including Continuous VenoVenous Hemodialysis (CVVHD) and Slow Continuous Ultrafiltration (SCUF). The Quanta Dialysis System stands out as the only dialysis device cleared by the FDA to provide Intermittent Hemodialysis (IHD), Sustained Low-Efficiency Dialysis (SLED), and Bagless CRRT. [Published On: 2023-08-03]

Rockwell Medical Announces 3-Year Co-Promotional Collaboration with B. Braun Medical

Rockwell Medical, Inc., a healthcare company, has entered into a 3-year co-promotion services agreement with B. Braun Medical Inc. As part of the agreement, B. Braun is planned to be compensated for any sales resulting from its promotional efforts. This strategic partnership allows Rockwell Medical to expand its customer base and generate new business leads, ultimately improving the lives of more hemodialysis patients. [Published On: 2023-06-29]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Continuous Renal Replacement Therapy Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Continuous Renal Replacement Therapy Market, highlighting leading vendors and their innovative profiles. These include Anjue Medical Equipment Co., Ltd., Asahi Kasei Medical Co., Ltd., B. Braun SE, Baxter International Inc., Biomedica Medizinprodukte GmbH, Braun & Co. Limited, CytoSorbents Corporation, DIAMED Medizintechnik GmbH, Fresenius Medical Care AG & Co. KGaA, Infomed SA, Joline GmbH & Co. KG, Medites Pharma spol. s.r.o, Medtronic PLC, Miromatrix Medical Inc., Nextkidney B.V., Nikkiso Co., Ltd., Ningbo Tianyi Medical Devices Co., Ltd., Nipro Corporation, Nuwellis, Inc., Quanta Dialysis Technologies Limited, SB-KAWASUMI LABORATORIES, INC., Shionogi & Company, Limited, Sphingotec GmbH, SWS Hemodialysis Care Co. Ltd., Thermo Fisher Scientific Inc., and Toray Medical Co., Ltd. by Toray Industries, Inc..

Market Segmentation & Coverage

This research report categorizes the Continuous Renal Replacement Therapy Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • CRRT Systems
    • Dialysates & Replacement Fluids
    • Disposables
      • Bodyline sets & tubes
      • Hemofilters
  • Modality
    • Continuous Venovenous Hemodiafiltration
    • Continuous Venovenous Hemodialysis
    • Continuous Venovenous Hemofiltration
    • Slow Continuous Ultrafiltration
  • Age Group
    • Adults
    • Pediatrics
  • Indication
    • Non-renal
    • Renal
  • End User
    • Dialysis Clinics
    • Homecare
    • Hospitals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidences of acute kidney injury (AKI) and chronic kidney diseases (CKD)
      • 5.1.1.2. Availability of improved CCRT systems for pediatric and neonatal patients
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of continuous renal replacement therapy procedure
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing research and development for enhanced safety and efficacy of CRRT
      • 5.1.3.2. Favorable government approvals for CRRT machines and techniques
    • 5.1.4. Challenges
      • 5.1.4.1. Technical complications associated with continuous renal replacement therapy
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Growing prevalence toward acute kidney injury (AKI) boosting a need for CRRT devices for seamless treatment procedures
    • 5.2.2. Modality: Utilization of continuous venovenous hemodiafiltration for liberal fluid management in renal therapies
    • 5.2.3. Age Group: Differing CRRT requirements among pediatric population
    • 5.2.4. Indication: Growing adoption of non-renal indications in extracorporeal renal therapies
    • 5.2.5. End User: Increasing uses of CRRT devices in hospitals to cater a patients need
  • 5.3. Market Trend Analysis
    • 5.3.1. Established companies in the North America receiving favorable government approvals for CRRT and their potential expansion in the South American market
    • 5.3.2. Growing number of renal patients in Asia leads to an increased need for continuous renal replacement therapies
    • 5.3.3. Supportive government policies and financial initiatives from established vendors for the kidney health contributed to CRRT advancement across EMEA
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework Analysis

6. Continuous Renal Replacement Therapy Market, by Product

  • 6.1. Introduction
  • 6.2. CRRT Systems
  • 6.3. Dialysates & Replacement Fluids
  • 6.4. Disposables

7. Continuous Renal Replacement Therapy Market, by Modality

  • 7.1. Introduction
  • 7.2. Continuous Venovenous Hemodiafiltration
  • 7.3. Continuous Venovenous Hemodialysis
  • 7.4. Continuous Venovenous Hemofiltration
  • 7.5. Slow Continuous Ultrafiltration

8. Continuous Renal Replacement Therapy Market, by Age Group

  • 8.1. Introduction
  • 8.2. Adults
  • 8.3. Pediatrics

9. Continuous Renal Replacement Therapy Market, by Indication

  • 9.1. Introduction
  • 9.2. Non-renal
  • 9.3. Renal

10. Continuous Renal Replacement Therapy Market, by End User

  • 10.1. Introduction
  • 10.2. Dialysis Clinics
  • 10.3. Homecare
  • 10.4. Hospitals

11. Americas Continuous Renal Replacement Therapy Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Continuous Renal Replacement Therapy Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Continuous Renal Replacement Therapy Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. B. Braun Receives FDA Clearance for AQUAbase nX Reverse Osmosis System
    • 14.3.2. Quanta Receives FDA 510(k) Clearance for Expanded Indication of Continuous Renal Replacement Therapies
    • 14.3.3. Rockwell Medical Announces 3-Year Co-Promotional Collaboration with B. Braun Medical
    • 14.3.4. Nuwellis, DaVita partner on ultrafiltration therapy pilot program
    • 14.3.5. Baxter, Miromatrix Partner on Liver Failure Research
    • 14.3.6. PBMC Launches New Renal Therapy Option for Dialysis Patients
    • 14.3.7. SeaStar Medical, Nuwellis Partner on Kidney Injury Treatment
    • 14.3.8. Spectral Medical Announces Strategic Joint Venture with Infomed to Accelerate Commercialization of DIMI and SAMI Dialysis Devices.
    • 14.3.9. Baxter Announces U.S. FDA Clearance of ST Set Used to Help Treat Acute Kidney Injury Patients in the Hospital

15. Competitive Portfolio

  • 15.1. Key Company Profiles
  • 15.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET RESEARCH PROCESS
  • FIGURE 2. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET DYNAMICS
  • FIGURE 7. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 16. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 20. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 25. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 26. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY CRRT SYSTEMS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY CRRT SYSTEMS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DIALYSATES & REPLACEMENT FLUIDS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DIALYSATES & REPLACEMENT FLUIDS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY BODYLINE SETS & TUBES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY BODYLINE SETS & TUBES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HEMOFILTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HEMOFILTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY CONTINUOUS VENOVENOUS HEMODIAFILTRATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY CONTINUOUS VENOVENOUS HEMODIAFILTRATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY CONTINUOUS VENOVENOUS HEMODIALYSIS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY CONTINUOUS VENOVENOUS HEMODIALYSIS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY CONTINUOUS VENOVENOUS HEMOFILTRATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY CONTINUOUS VENOVENOUS HEMOFILTRATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY SLOW CONTINUOUS ULTRAFILTRATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY SLOW CONTINUOUS ULTRAFILTRATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY ADULTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY ADULTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PEDIATRICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY NON-RENAL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY NON-RENAL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY RENAL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY RENAL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DIALYSIS CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DIALYSIS CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HOMECARE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HOMECARE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 51. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 52. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 53. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2023 (USD MILLION)
  • TABLE 54. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2024-2030 (USD MILLION)
  • TABLE 55. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
  • TABLE 56. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
  • TABLE 57. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
  • TABLE 58. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
  • TABLE 59. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 60. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 61. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 62. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 63. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 64. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 65. ARGENTINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 66. ARGENTINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 67. ARGENTINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2023 (USD MILLION)
  • TABLE 68. ARGENTINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2024-2030 (USD MILLION)
  • TABLE 69. ARGENTINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
  • TABLE 70. ARGENTINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
  • TABLE 71. ARGENTINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
  • TABLE 72. ARGENTINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
  • TABLE 73. ARGENTINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 74. ARGENTINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 75. ARGENTINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 76. ARGENTINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 77. BRAZIL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 78. BRAZIL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 79. BRAZIL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2023 (USD MILLION)
  • TABLE 80. BRAZIL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2024-2030 (USD MILLION)
  • TABLE 81. BRAZIL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
  • TABLE 82. BRAZIL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
  • TABLE 83. BRAZIL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
  • TABLE 84. BRAZIL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
  • TABLE 85. BRAZIL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 86. BRAZIL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 87. BRAZIL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 88. BRAZIL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 89. CANADA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 90. CANADA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 91. CANADA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2023 (USD MILLION)
  • TABLE 92. CANADA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2024-2030 (USD MILLION)
  • TABLE 93. CANADA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
  • TABLE 94. CANADA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
  • TABLE 95. CANADA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
  • TABLE 96. CANADA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
  • TABLE 97. CANADA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 98. CANADA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 99. CANADA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 100. CANADA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 101. MEXICO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 102. MEXICO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 103. MEXICO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2023 (USD MILLION)
  • TABLE 104. MEXICO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2024-2030 (USD MILLION)
  • TABLE 105. MEXICO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
  • TABLE 106. MEXICO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
  • TABLE 107. MEXICO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
  • TABLE 108. MEXICO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
  • TABLE 109. MEXICO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 110. MEXICO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 111. MEXICO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 112. MEXICO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 113. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 114. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 115. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2023 (USD MILLION)
  • TABLE 116. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2024-2030 (USD MILLION)
  • TABLE 117. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
  • TABLE 118. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
  • TABLE 119. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
  • TABLE 120. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
  • TABLE 121. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 122. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 123. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 124. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 125. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 126. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2023 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2024-2030 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 141. AUSTRALIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 142. AUSTRALIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 143. AUSTRALIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2023 (USD MILLION)
  • TABLE 144. AUSTRALIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2024-2030 (USD MILLION)
  • TABLE 145. AUSTRALIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
  • TABLE 146. AUSTRALIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
  • TABLE 147. AUSTRALIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
  • TABLE 148. AUSTRALIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
  • TABLE 149. AUSTRALIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 150. AUSTRALIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 151. AUSTRALIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 152. AUSTRALIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 153. CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 154. CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 155. CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2023 (USD MILLION)
  • TABLE 156. CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2024-2030 (USD MILLION)
  • TABLE 157. CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
  • TABLE 158. CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
  • TABLE 159. CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
  • TABLE 160. CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
  • TABLE 161. CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 162. CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 163. CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 164. CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 165. INDIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 166. INDIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 167. INDIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2023 (USD MILLION)
  • TABLE 168. INDIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2024-2030 (USD MILLION)
  • TABLE 169. INDIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
  • TABLE 170. INDIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
  • TABLE 171. INDIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
  • TABLE 172. INDIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
  • TABLE 173. INDIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 174. INDIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 175. INDIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 176. INDIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 177. INDONESIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 178. INDONESIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 179. INDONESIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2023 (USD MILLION)
  • TABLE 180. INDONESIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2024-2030 (USD MILLION)
  • TABLE 181. INDONESIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
  • TABLE 182. INDONESIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
  • TABLE 183. INDONESIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
  • TABLE 184. INDONESIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
  • TABLE 185. INDONESIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 186. INDONESIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 187. INDONESIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 188. INDONESIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 189. JAPAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 190. JAPAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 191. JAPAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2023 (USD MILLION)
  • TABLE 192. JAPAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2024-2030 (USD MILLION)
  • TABLE 193. JAPAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
  • TABLE 194. JAPAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
  • TABLE 195. JAPAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
  • TABLE 196. JAPAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
  • TABLE 197. JAPAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 198. JAPAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 199. JAPAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 200. JAPAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 201. MALAYSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 202. MALAYSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 203. MALAYSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2023 (USD MILLION)
  • TABLE 204. MALAYSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2024-2030 (USD MILLION)
  • TABLE 205. MALAYSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
  • TABLE 206. MALAYSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
  • TABLE 207. MALAYSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
  • TABLE 208. MALAYSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
  • TABLE 209. MALAYSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 210. MALAYSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 211. MALAYSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 212. MALAYSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 213. PHILIPPINES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 214. PHILIPPINES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 215. PHILIPPINES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2023 (USD MILLION)
  • TABLE 216. PHILIPPINES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2024-2030 (USD MILLION)
  • TABLE 217. PHILIPPINES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
  • TABLE 218. PHILIPPINES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
  • TABLE 219. PHILIPPINES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
  • TABLE 220. PHILIPPINES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
  • TABLE 221. PHILIPPINES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 222. PHILIPPINES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 223. PHILIPPINES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 224. PHILIPPINES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 225. SINGAPORE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 226. SINGAPORE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 227. SINGAPORE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2023 (USD MILLION)
  • TABLE 228. SINGAPORE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2024-2030 (USD MILLION)
  • TABLE 229. SINGAPORE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
  • TABLE 230. SINGAPORE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
  • TABLE 231. SINGAPORE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
  • TABLE 232. SINGAPORE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
  • TABLE 233. SINGAPORE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 234. SINGAPORE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 235. SINGAPORE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 236. SINGAPORE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 237. SOUTH KOREA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 238. SOUTH KOREA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 239. SOUTH KOREA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2023 (USD MILLION)
  • TABLE 240. SOUTH KOREA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2024-2030 (USD MILLION)
  • TABLE 241. SOUTH KOREA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
  • TABLE 242. SOUTH KOREA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
  • TABLE 243. SOUTH KOREA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
  • TABLE 244. SOUTH KOREA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
  • TABLE 245. SOUTH KOREA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 246. SOUTH KOREA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 247. SOUTH KOREA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 248. SOUTH KOREA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 249. TAIWAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 250. TAIWAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 251. TAIWAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2023 (USD MILLION)
  • TABLE 252. TAIWAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2024-2030 (USD MILLION)
  • TABLE 253. TAIWAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
  • TABLE 254. TAIWAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
  • TABLE 255. TAIWAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
  • TABLE 256. TAIWAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
  • TABLE 257. TAIWAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 258. TAIWAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 259. TAIWAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 260. TAIWAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 261. THAILAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 262. THAILAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 263. THAILAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2023 (USD MILLION)
  • TABLE 264. THAILAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2024-2030 (USD MILLION)
  • TABLE 265. THAILAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
  • TABLE 266. THAILAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
  • TABLE 267. THAILAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
  • TABLE 268. THAILAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
  • TABLE 269. THAILAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 270. THAILAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 271. THAILAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 272. THAILAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 273. VIETNAM CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 274. VIETNAM CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 275. VIETNAM CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2023 (USD MILLION)
  • TABLE 276. VIETNAM CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2024-2030 (USD MILLION)
  • TABLE 277. VIETNAM CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
  • TABLE 278. VIETNAM CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
  • TABLE 279. VIETNAM CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
  • TABLE 280. VIETNAM CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
  • TABLE 281. VIETNAM CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 282. VIETNAM CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 283. VIETNAM CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 284. VIETNAM CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 285. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 286. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 287. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2023 (USD MILLION)
  • TABLE 288. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2024-2030 (USD MILLION)
  • TABLE 289. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
  • TABLE 290. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
  • TABLE 291. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
  • TABLE 292. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
  • TABLE 293. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 294. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 295. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 296. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 297. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 298. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)

TABLE 299